Lifecore Biomedical Inc. Common Stock
LFCRUnited States
4 filed reports · 283 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
4 reports · May 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 3 | 873 | Sep 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 535 | May 2025 |
Financial data
283 concepts · 1,408 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial267 concepts · 1,288 facts · May 2023 to Jun 2026
- Allowance for doubtful accounts receivable11 · May 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents11 · May 2023 to Jun 2026
- Fair value measurement with unobservable inputs reconciliations recurring basis liability value11 · May 2023 to Jun 2026
- Stockholders equity (US GAAP)11 · May 2023 to Jun 2026
- Temporary equity carrying amount including portion attributable to noncontrolling interests11 · May 2023 to Jun 2026
- Temporary equity shares outstanding11 · May 2023 to Jun 2026
- Adjustments to additional paid in capital dividends in excess of retained earnings8 · May 2024 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value8 · May 2024 to Jun 2026
- Cost of goods and services sold (US GAAP)8 · May 2024 to Jun 2026
- Depreciation8 · May 2024 to Jun 2026
- Dividends paid-in-kind (in shares)8 · May 2024 to Jun 2026
- Earnings per share basic8 · May 2024 to Jun 2026
- Earnings per share diluted8 · May 2024 to Jun 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings8 · May 2024 to Jun 2026
- Gross profit (US GAAP)8 · May 2024 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest8 · May 2024 to Jun 2026
- Income tax expense benefit8 · May 2024 to Jun 2026
- Increase in carrying amount of redeemable preferred stock8 · May 2024 to Jun 2026
- Interest costs capitalized8 · May 2024 to Jun 2026
- Interest costs incurred8 · May 2024 to Jun 2026
- Interest expense debt8 · May 2024 to Jun 2026
- Net income loss8 · May 2024 to Jun 2026
- Net income loss available to common stockholders basic8 · May 2024 to Jun 2026
- Operating income loss8 · May 2024 to Jun 2026
Segment15 concepts · 104 facts · May 2024 to Jun 2026
- Allocated share based compensation expense8 · May 2024 to Jun 2026
- Depreciation8 · May 2024 to Jun 2026
- Income tax expense benefit8 · May 2024 to Jun 2026
- Interest income expense nonoperating net8 · May 2024 to Jun 2026
- Labor and related expense8 · May 2024 to Jun 2026
- Materials and non-depreciation overhead8 · May 2024 to Jun 2026
- Net income loss8 · May 2024 to Jun 2026
- Other nonoperating income expense8 · May 2024 to Jun 2026
- Reorganization costs8 · May 2024 to Jun 2026
- Revenue8 · May 2024 to Jun 2026
- Segment reporting other item amount8 · May 2024 to Jun 2026
- Gain loss on sale of other assets6 · May 2024 to Jun 2026
- Fair value measurement with unobservable inputs reconciliation recurring basis liability gain loss included in earnings4 · May 2024 to Sep 2025
- Fair value net derivative asset liability measured on recurring basis unobservable inputs reconciliation gain loss included in earnings4 · Feb 2025 to Jun 2026
- Income loss from discontinued operations net of tax attributable to reporting entity2 · May 2024 to May 2025
Product1 concepts · 16 facts · May 2024 to Jun 2026
- Revenue16 · May 2024 to Jun 2026
Segments
120 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 104 facts
- Reportable104 · May 2024 to Jun 2026
Product or service2 members · 16 facts
- Contract Development And Manufacturing Organization8 · May 2024 to Jun 2026
- HA Manufacturing8 · May 2024 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Jan 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2025 Q4Mar 16, 2026
- FY2025 Q3Apr 3, 2025
- FY2025 Q2Jan 2, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.